GlassScriptPhysician profile
Caroline Negron
NPI 1487960340
$5,179.74
in general payments reported to CMS, 2019-2025
25 companies · $1,892 in 2025
The $1,892 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $855 · 2024: $2,433 · 2025: $1,892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,179.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,051.92 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $875.93 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $758.99 | 2023-2025 | Jardiance, Zepbound, Mounjaro |
| Abbvie INC. | $536.47 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $421.86 | 2023-2025 | |
| Glaxosmithkline, LLC. | $388.23 | 2023-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Exact Sciences Corporation | $248.03 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $220.27 | 2024-2025 | Jardiance |
| Amgen INC. | $105.80 | 2024-2025 | Repatha, Otezla, Prolia |
| Renalytix Ai, INC. | $96.49 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Dexcom, INC. | $50.64 | 2024 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $48.21 | 2024 | |
| Janssen Pharmaceuticals, INC | $43.91 | 2024 | Xarelto |
| Si-Bone, INC. | $43.43 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $43.02 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $39.83 | 2023-2025 | Heplisav-B |
| Medtronic, INC. | $30.97 | 2024 | Intellis Adaptivestim, Venaseal |
| Boston Scientific Corporation | $28.91 | 2025 | General - Pain Management |
| Pfizer INC. | $28.27 | 2023-2024 | |
| Hologic Sales and Service, LLC | $25.18 | 2023 | Thinprep 2000 Processor, Aptima |
| Corcept Therapeutics | $24.94 | 2025 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.60 | 2024 | Xifaxan |
| Shield Therapeutics INC | $19.35 | 2024 | |
| Lucid Diagnostics INC. | $15.62 | 2025 | |
| Idorsia Pharmaceuticals US INC | $12.87 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Negron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.